CIK 0001527753 · Non-accelerated filer<br>Smaller reporting company
Personalis, Inc.
Sign in to watch- Ticker
- PSNL
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 275411038
- Phone
- 650-752-1300
- Business address
- 6600 DUMBARTON CIRCLE, FREMONT, CA, 94555
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $728,924
- in 5 filings
Net −$728,924. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-05-17 | EASTHAM KARIN Director | Grant or award | +10,770 | 13,506 | ||
| 2022-05-17 | EASTHAM KARIN Director | Grant or award · Stock Option (right to buy) | +15,035 | 15,035 | ||
| 2022-05-17 | BOWMAN A BLAINE Director | Grant or award | +10,770 | 13,506 | ||
| 2022-05-17 | BOWMAN A BLAINE Director | Grant or award · Stock Option (right to buy) | +15,035 | 15,035 | ||
| 2022-05-17 | Colowick Alan Director | Grant or award | +10,770 | 13,506 | ||
| 2022-05-17 | Colowick Alan Director | Grant or award · Stock Option (right to buy) | +15,035 | 15,035 | ||
| 2022-05-17 | LUDLUM KEN Director | Grant or award | +10,770 | 43,506 | ||
| 2022-05-17 | LUDLUM KEN Director | Grant or award · Stock Option (right to buy) | +15,035 | 15,035 | ||
| 2022-05-16 | Tachibana Aaron Chief Financial Officer | Sale | −1,286 | $4.86 | $6K | 246,388 |
| 2022-05-16 | West John Stephen President and CEO | Sale | −2,408 | $4.86 | $12K | 382,444 |
| 2022-05-16 | Moore Stephen Michael General Counsel | Sale | −664 | $4.86 | $3K | 75,717 |
| 2022-05-16 | Chen Richard Chief Medical Officer | Sale | −1,286 | $4.86 | $6K | 155,830 |
| 2022-05-02 | Moore Stephen Michael General Counsel | Sale | −5,733 | $5.53 | $32K | 76,381 |
| 2022-04-29 | Chen Richard Chief Medical Officer | Grant or award | +1,558 | $4.76 | $7K | 157,116 |
| 2022-04-20 | West John Stephen President and CEO | Option exercise | +45,061 | $1.84 | $83K | 384,852 |
| 2022-04-20 | West John Stephen President and CEO | Option exercise · Stock Option (Right to Buy) | −45,061 | 0 | ||
| 2022-04-13 | West John Stephen President and CEO | Option exercise | +64,430 | $1.84 | $119K | 404,221 |
| 2022-04-13 | West John Stephen President and CEO | Sale | −64,430 | 339,791 | ||
| 2022-04-13 | West John Stephen President and CEO | Returned to the company · Stock Option (Right to Buy) | −64,430 | 0 | ||
| 2022-03-17 | West John Stephen President and CEO | Grant or award | +54,347 | $1.84 | $100K | 339,804 |
Page 11 of 23 · 444 trades